A colorectal cancer drug developed by Sanofi-Aventis (NYSE:SNY) and Regeneron Pharmaceuticals (NASDAQ:REGN) has received approval from the U.S. Food and Drug Administration. Zaltrap is designed to be used in combination with folinic acid, fluorouracil and irinotecan, a commonly used chemotherapy treatment for adults, according to an FDA statement. The drug interferes with blood supply to […]
A big data group with a plan to reduce the cost of diabetes care by identifying and tracking people in the early stages of diabetes who under use healthcare emerged as the winner of Sanofi’s (NYSE:SNY) crowdsourcing competition to uncover innovative approaches to improve the quality, delivery and cost of care for diabetes. The National […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A U.S. Food and Drug committee moved against recommending for approval Sanofi-Aventis’ (NYSE:SNY) blood thinner for patients on chemotherapy in a resounding 14 to 1 vote against semuloparin. Semuloparin was designed to treat patients with certain cancers at higher risk for blood clots. The oncologic drugs advisory committee said the findings of the phase 3 […]
Bristol-Myers Squibb (NYSE:BMY) and Sanofi (NYSE:SNY) bid goodbye to their exclusive patent for blockbuster drug Plavix with the U.S. Food and Drug Administration’s approval of generic versions of the blood-thinning drug to nine pharmaceutical companies today, signaling the drug’s fall down the patent cliff. Plavix reached peak sales of more than $7 billion last year, […]
To identify people with diabetes who underutilize healthcare, you don’t need real-time video hookups or smartphone apps. You just need a lot of data to find the people and a big physical infrastructure to deliver the care. That’s the approach the National Association of Area Agencies on Aging is proposing to cut the costs of diabetes […]
One of the most significant factors influencing healthcare costs is patient adherence or lack thereof. If diabetes patients don’t take their medications, watch what they eat and monitor their blood-glucose levels, they risk complications that can lead to hospitalization. A semifinalist in Sanofi US’ (NYSE:SNY) Data Design Diabetes Innovation Challenge, iRetainRx believes it can overcome […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Sanofi (NYSE:SNY) CEO Chris Viehbacher has definite thoughts about how to marry life science ideas with the financing that is the life blood for that innovation. The pharmaceutical giant earlier this year partnered with venture capital firm Third Rock Ventures to launch biotechnology company Warp Drive Bio. Supporting biotech company launches is not a typical […]